Two types of poor immunological responder showing distinct responses to long-term HAART

Int J Infect Dis. 2019 Sep:86:178-187. doi: 10.1016/j.ijid.2019.07.037. Epub 2019 Aug 6.

Abstract

Objectives: Most previous studies on poor immunological responders (PIRs) have been performed on one cohort at one time-point following highly active antiretroviral therapy (HAART). The aim of this study was to investigate whether there are different subtypes of PIR and whether a certain population might achieve better immune reconstitution following longer HAART.

Methods: This study was designed as an ambispective cohort study, including a 4-5-year retrospective study and a 2-year prospective follow-up investigation. Thymic output, activated T cell and regulatory T cell (Treg) subset frequencies, expression levels of interferon-stimulated genes, and plasma concentrations of neopterin were determined at 4-5 years and 6-7 years following HAART initiation.

Results: PIRs were subdivided into two populations after 4-5 years of HAART, according to the kinetics of T cell recovery. Type II PIRs exhibited a significantly lower percentage of naïve CD4+ T cells and CD31+ naïve CD4+ T cells compared with type I PIRs. After an additional 2 years of HAART treatment, type I PIRs showed a better outcome than type II PIRs. Furthermore, it was found that 2 years of additional HAART could persistently improve thymic output.

Conclusions: The two PIR subgroups are different in terms of immune characteristics and the response to prolonged HAART.

Keywords: Long-term HAART; Poor immunological responders; Subdivision; Thymic output.

MeSH terms

  • Adult
  • Antiretroviral Therapy, Highly Active*
  • CD4 Lymphocyte Count
  • Cohort Studies
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • HIV Infections / drug therapy*
  • HIV Infections / immunology*
  • HIV-1 / immunology
  • Humans
  • Lymphocyte Activation
  • Male
  • Prospective Studies
  • Retrospective Studies
  • T-Lymphocytes, Regulatory / immunology
  • Viral Load